Cancilico

Key Facts

Invested since	2025
Based in	Dresden

About the company

Cancilico is a Dresden-based health-tech startup founded in 2023 as a spin-off of the EKFZ for Digital Health at TUD Dresden University of Technology and University Hospital Dresden. The company develops AI-driven diagnostic solutions for hematology, aimed at automating and improving the accuracy of blood and bone marrow analysis. Its mission is to bring cutting-edge AI technology into routine hematology labs, improving the state of care for blood cancer patients around the world and the development of digital biomarkers in hematology. The founding team includes Markus Badstübner, Dr. Moritz Middeke, Tim Schmittmann, Sebastian Riechert, Dr. Jan Eckardt, Dr. Karsten Wendt, and Angel Investor Prof. Gerhard Ehninger.

Cancilico is deeply embedded in the Saxon life science ecosystem, engaging with the regional biotech network Biosaxony, and strongly contributing to the SaxoCell and SEMECO Clusters4Future initiatives. Within these clusters, startups such as Cancilico can further develop their strong founding dynamics and combine them with rapid translational pathways.

cancilico.com/

Do you want to

know more about this company?

Zum Artikel

Dr. Jörg Traub Principal

Write me

Cancilico in the news

zum Artikel

News

20 January 2026

Cancilico Raises €2.5M to Scale AI-Powered Bone Marrow Diagnostics

More startups from Life Sciences

12 of 500 Companies

Backed

Cancilico

Key Facts

About the company

Do you want to

know more about this company?

Dr. Jörg Traub Principal

Dr. Jörg TraubPrincipal

Cancilico in the news

Cancilico Raises €2.5M to Scale AI-Powered Bone Marrow Diagnostics

Cancilico Raises €2.5M to Scale AI-Powered Bone Marrow Diagnostics

More startups from Life Sciences

DNTOX

DNTOX GmbH was founded in March 2022 as a spin-off from the IUF – Leibniz Institute for Environmental Medicine Research and is based on the longstanding research work of Professor …

Rigontec

Rigontec GmbH is a preclinical biotech company developing RNA-based immunotherapeutics for the treatment of cancer and viral diseases. Rigontec’s lead compound ImOl100 targets a novel receptor of the innate immune …

GME

GME German Medical Engineering develops and markets a new generation of laser and lightsystems (small, light weight, modular) for the use in cosmetic and medical dermatology.

mbiomics

Mbiomics is a Munich based microbiome startup company which was founded by Dr. Laura Figulla (CEO), Dr. Johannes Wöhrstein (CTO), and Dr. Markus Rinecker (CMO) in 2020. With its proprietary …

Immunic

Immunic Therapeutics is a clinical-stage biotech company with a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases. Immunic, Inc. is headquartered in New York. …

Cunesoft

Cunesoft provides pioneering online regulatory software for the life sciences and other regulated industries. The SaaS (Software as a Service) based solutions are delivered fully functional to customers and fulfill …

OMEICOS

OMEICOS Therapeutics develops a novel, first-in-class, small molecule drug addressing a new Mode of Action for the treatment and prevention of atrial fibrillation.

cutanos

Cutanos GmbH is a biotech company founded in early 2021 focussing on the development of antigen-specific vaccines and new treatments for autoimmune disorders. Cutanos uses a modular and highly flexible …

Cancilico

Cancilico is a Dresden-based health-tech startup founded in 2023 as a spin-off of the EKFZ for Digital Health at TUD Dresden University of Technology and University Hospital Dresden. The company …

HBOX Therapies

HBOX Therapies has developed a technology that facilitates lung-protective treatment of respiratory patients, the patented platform technology HBOX (Hyperbaric Blood Oxygenation). The management team of HBOX Therapies consists of the …

TRIM TX

TRIM TX is developing best-in-class Gamma-Secretase-Stabilizers (GSS) for the prevention and treatment of Alzheimer Disease.

O11 biomedical

O11 biomedical, a visionary medical technology start-up that emerged as part of BioTex at RWTH Aachen University/ University Hospital Aachen 2022, aims to improve survival rates and quality of life …